Indications and uses
Hepatoprotection 420 mg daily divided into 3 doses for 6-8 wk. Maintenance dose: 280 mg daily.
Hepatoprotection 420 mg daily divided into 3 doses for 6-8 wk. Maintenance dose: 280 mg daily.
Oral
Silymarin (Extract from seeds of Milk Thistle (Silybum marianum) 70 mg
Acute, chronic & infective hepatitis; liver cirrhosis; non-alcoholic fatty liver disease/non-alcoholic steatohepatitis; alcoholic liver disease.
Hepatoprotection 420 mg daily divided into 3 doses for 6-8 wk.
Maintenance dose: 280 mg daily.
Silymarin may inhibit cytochrome P450 2C9 and CYPP4503A4; but no effect on pharmacokinetics of indinavir in human studies. Silymarin may decrease blood glucose in patients with cirrhosis and diabetes.
Oral
spray dried Lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, magnesium stearate, butylated hydroxytoluene, opadry brown (85G56726), hydroxypropyl methylcellulose (hypromellose 15), propylen glycol, titanium dioxide, talcum.
Questions? Email: customerservice@lviva.com
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 72430-005 | 72430-005-01, 72430-005-02, 72430-005-03 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1cf97c4e-2073-a355-e063-6394a90aa5a8 | 59178bc0-0e0c-4b7e-999f-94510cdca918 | 2024-07-11 | Warnings | 59178bc0-0e0c-4b7e-999f-94510cdca918 |
Adverse event summaries are temporarily unavailable. Other product information remains available.